Hikma Pharmaceuticals Plc (OTCMKTS:HKMPF – Get Free Report) shares reached a new 52-week low on Friday . The company traded as low as $19.9825 and last traded at $19.9825, with a volume of 1717 shares. The stock had previously closed at $20.48.
Hikma Pharmaceuticals Stock Down 2.0%
The company has a debt-to-equity ratio of 0.33, a current ratio of 1.24 and a quick ratio of 0.72. The business has a 50-day moving average price of $21.93 and a 200-day moving average price of $24.32.
About Hikma Pharmaceuticals
Hikma Pharmaceuticals is a multinational pharmaceutical company that develops, manufactures and markets a broad range of branded and non-branded generics, specialty injectables and consumer healthcare products. The company’s three core business segments include generic medicines, injectable products and branded generics, serving hospitals, wholesalers and pharmacies worldwide. Its product portfolio spans diverse therapeutic areas such as cardiovascular, oncology, respiratory, pain management and anti-infectives, with an emphasis on injectable solutions for complex hospital treatments.
Founded in 1978 in Amman, Jordan, Hikma has grown through organic expansion and strategic acquisitions to become one of the leading pharmaceutical players in the Middle East, North Africa, Europe and the United States.
Featured Stories
- Five stocks we like better than Hikma Pharmaceuticals
- How to Use the MarketBeat Stock Screener
- Nike Beats on Earnings But Struggles in China and Faces Tariffs
- Ride Out The Recession With These Dividend Kings
- Is the AI Boom a Bubble? These 2 Dividend Stocks Say No
- What is a Dividend Harvesting Strategy and How Can Investors Profit from it?
- 4 High-Potential ETFs for 2026: Small Caps, Space Stocks, and More
Receive News & Ratings for Hikma Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hikma Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
